GOLDMAN SACHS GROUP INC - Mar 31, 2025 SCHEDULE 13G/A Report for SYNDAX PHARMACEUTICALS, INC. Common Stock (SNDX)

Filing Manager: GOLDMAN SACHS GROUP INC
Reporting Manager: THE GOLDMAN SACHS GROUP, INC.
Security: SYNDAX PHARMACEUTICALS, INC. Common Stock
Symbol: SNDX
Shares outstanding: 86.7M shares
Disclosed Ownership: 4.51M shares
Ownership: 5.2%
Form type: SCHEDULE 13G/A
Date filed: 5/9/2025, 12:34 PM
Date of event: Mar 31, 2025
Previous filing: Feb 12, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
THE GOLDMAN SACHS GROUP, INC.	5.2%	4.51M	0	4.51M	Name: AMEEN SOETAN	Attorney-in-fact
GOLDMAN SACHS & CO. LLC	5.2%	4.51M	0	4.51M	Name: AMEEN SOETAN	Attorney-in-fact